Next Science
Chatswood
About Next Science
Next Science provides commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $15.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2023)
- Ticker: asx:NXS
- Website: nextscience.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/next-science-203032 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.